| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $669K | +6.0% |
| SG&A Expense | $6.8M | +338.7% |
| Operating Income | -$8.5M | -233.9% |
| Net Income | -$8.5M | -233.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | +509.1% |
| Current Assets | $3.7M | +475.4% |
| Total Assets | $4.6M | +211.6% |
| Current Liabilities | $199K | -40.9% |
| Total Liabilities | $199K | -40.9% |
| Stockholders' Equity | $4.4M | +285.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | -42.0% |
| Capital Expenditures | $14K | -92.8% |
| Investing Cash Flow | -$139K | +64.5% |
| Financing Cash Flow | $4.7M | +127.5% |
| Free Cash Flow | -$1.5M | -20.9% |